Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Neoplasm Metastasis 5Prostatic Neoplasms 4Sarcoma 3Neoplasms 3Pancreatic Neoplasms 2Neuroblastoma 2Hodgkin Disease 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Urologic Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Soft Tissue Neoplasms 1Recurrent Uterine Sarcoma 1Recurrence 1Pharyngeal Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neurofibromatosis 2 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Mesothelial 1Mouth Neoplasms 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphangioleiomyomatosis 1Liver Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1

Interventions

Cyclophosphamide 10fludarabine phosphate 9Peripheral Blood Stem Cell Transplantation 8Busulfan 8Antilymphocyte Serum 8Mycophenolic Acid 7Whole-Body Irradiation 6Tacrolimus 6Methylprednisolone 6Methotrexate 6Cyclosporine 6Radiotherapy 5Filgrastim 5Cord Blood Stem Cell Transplantation 5Sirolimus 4Rituximab 4Flow Cytometry 4Cytarabine 4Thiotepa 3Melphalan 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Dasatinib 3venetoclax 2ponatinib 2aldesleukin 2Tretinoin 2Therapeutics 2Sunitinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Blast Crisis × temsirolimus × Clear all
NCT00101088 2013-01-14

Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 1 Terminated
21 enrolled
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡